Prevenar (13v) Infant Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2017
Price : $35 *
At a glance
- Drugs Pneumococcal vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Pfizer
- 18 Jul 2016 Status changed from active, no longer recruiting to completed.
- 09 Feb 2016 Planned End Date changed from 1 Feb 2016 to 1 May 2016 as reported by ClinicalTrials.gov.
- 09 Feb 2016 Planned primary completion date changed from 1 Feb 2016 to 1 May 2016 as reported by ClinicalTrials.gov.